Early Mobilisation in the Surgical Robot Assisted Spinal Surgery
NCT ID: NCT04133103
Last Updated: 2019-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2019-10-16
2020-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First ambulation at 24 hours after operation
No interventions assigned to this group
First ambulation at 4 hours after operation
first ambulation at 4 hour after operation
Two groups were conducted for first ambulation at 4 or 24 hours aftër operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
first ambulation at 4 hour after operation
Two groups were conducted for first ambulation at 4 or 24 hours aftër operation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* single level instrumentation sugery
* sign informed consent
Exclusion Criteria
* diagnosis of severe osteoperosis (BMD \< 60mg/cm3) by QCT
* coagulant function abnormality
* severe internal disease
* not suitable for inclusion
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Jishuitan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wei Tian
director of spine department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei Tian
Role: STUDY_DIRECTOR
Beijng Jishuitan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wei Tian
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Wei Tian
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Jilunke201909-24
Identifier Type: -
Identifier Source: org_study_id